Emami Q1 Results: Earnings call audio link released for investors

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Emami Limited released the audio recording of its Q1FY27 earnings call held on August 4, 2026. The call discussed unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The disclosure was made to NSE and BSE in compliance with SEBI Regulation 30.

powered bylight_fuzz_icon
47406340

*this image is generated using AI for illustrative purposes only.

Emami Limited has made available the audio recording of its conference call with analysts and investors, providing insights into the company’s unaudited financial performance for the quarter ended June 30, 2026. The call took place on August 4, 2026, following the declaration of both standalone and consolidated results for Q1FY27. This disclosure ensures transparency and allows stakeholders to review management’s commentary on the latest financial outcomes directly.

The announcement was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Emami Limited submitted the link to the audio recording to both the National Stock Exchange of India Ltd. and BSE Limited on August 4, 2026. The filing was signed by Ravi Varma, Company Secretary & Compliance Officer (Membership No: F9531), confirming the regulatory compliance of the disclosure.

Key Details of the Disclosure

Particulars Details
Event Conference Call with Analysts / Investors
Date Held August 4, 2026
Financial Period Quarter ended June 30, 2026 (Q1FY27)
Result Type Unaudited Financial Results (Standalone & Consolidated)

The audio recording is hosted on the company’s investor relations website. Investors seeking to understand the drivers behind the quarterly performance, including operational highlights and financial metrics, can access the recording through the provided link. This step is part of standard corporate governance practices, ensuring that all market participants have equal access to material information discussed during the earnings briefing.

No specific financial figures such as net profit, revenue, or EBITDA were included in this particular filing, as it serves solely as a pointer to the audio resource. However, the availability of the call transcript allows for a deeper dive into the strategic initiatives and market conditions affecting Emami Limited during the period. Stakeholders are advised to refer to the separate financial results filings for detailed numerical data.

What the Numbers Show

While this specific document does not contain quantitative financial data, the timing of the call immediately post-result declaration indicates a focus on clarifying the unaudited standalone and consolidated outcomes for Q1FY27. The emphasis on compliance with Regulation 30 underscores the company's adherence to listing obligations, ensuring that the narrative surrounding the financial results is accessible to all investors simultaneously.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-0.71%-0.44%-1.27%-15.17%-31.22%-31.53%

How might management's commentary on Q1FY27 operational highlights influence Emami's stock valuation in the upcoming quarters?

What specific strategic initiatives did leadership emphasize during the call to drive growth in the competitive FMCG sector?

Are there any indications from the conference call regarding potential changes in dividend policy or capital allocation for FY27?

Emami Q1FY26: Domestic Sales Surge 20%, Volume Grows 8% Amid Profit Dip

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Emami posted a 15.4% decline in consolidated net profit to ₹1,389.40 lacs in Q1FY26, even as revenue from operations rose 15% to ₹1,039.21 lacs. Domestic sales surged 20% (12% like-for-like) with 8% volume growth. Higher tax expenses and acquisition-related costs weighed on profitability, while strategic acquisitions of Axiom Ayurveda and IncNut Digital expanded the company's portfolio.

powered bylight_fuzz_icon
47377766

*this image is generated using AI for illustrative purposes only.

Emami reported a mixed performance for the first quarter of FY26 (ended June 30, 2026), with consolidated net profit declining 15.4% year-on-year to ₹1,389.40 lacs, while revenue from operations grew 15% to ₹1,039.21 lacs. Domestic sales increased by 20%, with a 12% growth on a like-for-like basis, and the company recorded a volume growth of 8% for the quarter. The Board of Directors approved the unaudited financial results on August 4, 2026. The decline in profitability despite top-line growth was driven by higher tax expenses and the integration costs associated with recent acquisitions, including Axiom Ayurveda Private Limited and IncNut Digital Private Limited.

Financial Performance

The company's consolidated revenue from operations stood at ₹1,039.21 lacs for Q1FY26, up from ₹904.09 lacs in the corresponding quarter of FY25. Other income decreased to ₹18.50 lacs from ₹21.59 lacs. Total income for the quarter was ₹1,057.71 lacs.

Consolidated EBITDA rose marginally to ₹2,446.80 lacs from ₹2,358.10 lacs year-on-year. However, the EBITDA margin contracted to 23.54% from 26.08%. Finance costs increased significantly to ₹5.61 lacs from ₹2.43 lacs. Depreciation and amortization expenses remained relatively stable at ₹42.76 lacs. The following table summarizes the key consolidated financial metrics for the quarter:

Metric Q1FY26 (₹ Lacs) Q1FY25 (₹ Lacs) Change
Revenue from Operations 1,039.21 904.09 +15.0%
EBITDA 2,446.80 2,358.10 +3.8%
Net Profit After Tax 1,389.40 1,642.60 -15.4%
EPS (Basic) ₹3.15 ₹3.76 -16.2%

The total tax expense for the quarter was ₹55.77 lacs, compared to ₹22.51 lacs in Q1FY25. This increase was partly due to the utilization of Minimum Alternate Tax (MAT) credit. The company utilized ₹13.45 lacs of MAT credit during the quarter, bringing the remaining MAT credit balance to ₹604.92 lacs as of June 30, 2026.

Operational Highlights

Emami's domestic business demonstrated strong momentum during the quarter, with domestic sales rising 20% overall and 12% on a like-for-like basis, reflecting underlying demand strength. The company also recorded a volume growth of 8% for Q1FY26, indicating healthy consumer offtake across its product portfolio.

Strategic Acquisitions

Emami expanded its portfolio through two significant acquisitions during the quarter. On April 1, 2026, the company acquired a controlling stake in Axiom Ayurveda Private Limited by paying a first tranche consideration of ₹100 crores towards a total agreed consideration not exceeding ₹200 crores. This transaction converted Axiom into a subsidiary, and its financial results have been consolidated from April 1, 2026.

Additionally, on June 1, 2026, Emami acquired a 60% controlling stake in IncNut Digital Private Limited for a consideration of ₹320.99 lacs under a Share Subscription and Purchase Agreement dated May 7, 2026. The remaining 40% shareholding will be acquired through subsequent tranches over the next four years. Both acquisitions were accounted for as business combinations under IND AS 103, making the current quarter's financials not directly comparable with previous periods.

Auditor's Qualified Conclusion

S.R. Batliboi & Co. LLP, the statutory auditors, issued a qualified conclusion on the consolidated financial results. The qualification arises because the interim financial results of certain subsidiaries and associates were not reviewed by their respective component auditors. Specifically, the results of one subsidiary group (revenue ₹80.20 lacs, net profit ₹5.32 lacs), another subsidiary group (revenue ₹14.69 lacs, net loss ₹0.92 lacs), and two associates (group share of net loss ₹1.55 lacs) were included based on management-provided unaudited figures. The auditors stated they are unable to comment on the potential financial impact if these entities had been reviewed.

Standalone Results

On a standalone basis, Emami reported a net profit of ₹1,822.20 lacs for Q1FY26, an increase from ₹1,630.90 lacs in Q1FY25. Standalone revenue from operations grew 3.1% to ₹779.92 lacs from ₹756.46 lacs. Standalone EBITDA improved to ₹2,686.20 lacs from ₹2,214.80 lacs. The standalone tax expense was ₹51.38 lacs, including ₹13.45 lacs of MAT credit utilization.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-0.71%-0.44%-1.27%-15.17%-31.22%-31.53%

How will the integration of Axiom Ayurveda and IncNut Digital impact Emami's EBITDA margins in the subsequent quarters as one-time costs stabilize?

What is the timeline for Emami to acquire the remaining 40% stake in IncNut Digital, and how might this affect future capital allocation strategies?

Given the auditor's qualified conclusion regarding unaudited subsidiary figures, what steps will management take to ensure full compliance and transparency in upcoming financial reports?

More News on Emami

1 Year Returns:-31.22%